Compare
PCRX vs SPY
Up to five stocks or ETFs side by side. Performance is rebased to 100 at the start of the window.
Relative performance
| PCRX | SPY | |
|---|---|---|
| Price | $36.43 | $735.29 |
| 1-day | +0.03% | +0.31% |
| YTD | +40.77% | +7.83% |
| 1 year | +66.73% | +8.52% |
| 3 years | +28.68% | +73.97% |
| Market cap | $1.5B | — |
| P/E | 39.2 | — |
| P/S | 1.97 | — |
| P/B | 2.05 | — |
| Revenue growth | +3.70% | — |
| EPS growth | +102.20% | — |
| Gross margin % | 78.7 | — |
| Net margin % | 5.1 | — |
| ROE % | 5.3 | — |
| Debt / equity | 0.41 | — |
| FCF yield % | 11.6 | — |
| Dividend yield % | — | — |
| Beta | 0.12 | 1.00 |
| RSI (14) | 83.2 | 35.1 |
| Technical rating |